If you have trouble viewing the newsletter, please click here.

Dear ESOP-members!

In this newsletter, we would like to draw attention to The European Journal of Oncology Pharmacy (EJOP). EJOP offers you the opportunity to publish your scientific studies and be known all over the world and also, EJOP website is now live and can be accessed by all.

Best regards,


Eda Gedikoglu
Chair of Publication


EJOP provides to the global readers updated and most important information in the mode of original articles, review articles, case reports, short communications, etc. The journal will be interested in featuring articles discussing the multi- professional approaches of patient care.

The Editor-in-Chief of the journal is Professor Alain Astier, University Hospital Henri Mondor, Paris 12 University. As Prof Astier said: "I am convinced that EJOP should be the journal of reference for pharmacists working in the field of oncology.

However, we believe that EJOP could also be an excellent multidisciplinary publication platform for those interested in all the aspects of the pharmacological approach to cancer treatment. Our editorial board is constituted of recognized worldwide specialists from all the major fields of oncology pharmacy, thus guaranteeing the highest quality of the published papers."

ESOP is honored to support all pharmacists who want to contribute to oncology with scientific studies.

Please submit articles under:


Download the info sheet (PDF) »

If you don't want to recieve any further ESOP Newsletters, please click to unsubscribe.